This is the 10th US patent issued to Dyadic adding to its portfolio of 74 international patents.
The inventions exhibited by this patent relate to the use of and methods for producing novel enzymes and their combinations to convert lignocellulosic biomass into fermentable sugars.
The inventions also relate to methods of using novel enzymes and their combinations in a variety of other processes including the simultaneous production of organic substances such as alcohol, ethanol, amino and organic acids as well as other organic substances.
The enzymes were isolated from Dyadic’s patented and proprietary C1 fungus and additionally identified through the genome annotation project conducted by Dyadic in conjunction with Scripps Florida.
Dyadic president and CEO Mark Emalfarb said the patent provides the company with additional protection in the use of unique enzymes generated from Dyadic’s C1 platform technology to unlock the economic power of converting plentiful feedstocks of plant materials into sugars which inturn produce chemicals, plastics and fuels.